Ziprasidone in the treatment of delayed carbon... (2006 study) Skip to main content
Case Report Prog Neuropsychopharmacol Biol Psychiatry 2006

Ziprasidone in the treatment of delayed carbon monoxide encephalopathy

Hu M, Shiah I, Yeh C, Chen H, Chen C, Prog Neuropsychopharmacol Biol Psychiatry, 2006

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors described the case of one woman who developed lasting brain and behaviour problems after carbon monoxide poisoning and who was then given a medicine called ziprasidone.

What They Found

This case report describes a 52-year-old woman whose delayed neuropsychiatric symptoms after carbon monoxide poisoning improved after 10 days of ziprasidone at 80 mg per day. She had tried to end her life by burning charcoal and was first treated with hyperbaric oxygen (HBO) therapy for the acute poisoning. One week later she developed parkinsonism, tardive dyskinesia, cognitive decline, urinary incontinence, gait disturbance, mutism, disorientation and disorganized behaviour. Daily HBO therapy, bromocriptine (2.5 mg per day), sulpiride (600 mg per day), risperidone (5 mg per day) and quetiapine (400 mg per day) were given, yet her symptoms persisted. After ziprasidone, the authors report substantial improvement in her symptoms, thinking and daily activities.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a report of one patient with no comparison group, and she received several treatments in sequence, so the abstract cannot show that ziprasidone alone caused her improvement.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Neurological
Source Pubmed
PubMed ID 16581170
Year Published 2006
Journal Prog Neuropsychopharmacol Biol Psychiatry
MeSH Terms Antipsychotic Agents; Brain Diseases; Carbon Monoxide Poisoning; Female; Humans; Middle Aged; Piperazines; Thiazoles

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology